Norveška -
norveški -
Statens legemiddelverk
kloramfenikol 10 mg/ g
takeda as - kloramfenikol - Øyesalve - 10 mg/ g
Norveška -
norveški -
Statens legemiddelverk
kloramfenikol 5 mg/ ml
takeda as - kloramfenikol - Øyedråper, oppløsning - 5 mg/ ml
Norveška -
norveški -
Statens legemiddelverk
nycoplus c-vitamin 1000 mg
takeda as - askorbinsyre - brusetablett med sitronsmak - 1000 mg
Norveška -
norveški -
Statens legemiddelverk
nycoplus c-vitamin 1000 mg
takeda as - askorbinsyre - brusetablett med appelsinsmak - 1000 mg
Norveška -
norveški -
Statens legemiddelverk
nycoplus e-vitamin 350 mg
takeda as - tokoferol - kapsel, myk - 350 mg
Norveška -
norveški -
Statens legemiddelverk
petidin 100 mg
takeda as - petidinhydroklorid - stikkpille - 100 mg
Norveška -
norveški -
Statens legemiddelverk
petidin 50 mg/ ml
takeda as - petidinhydroklorid - injeksjonsvæske, oppløsning - 50 mg/ ml
Norveška -
norveški -
Statens legemiddelverk
vitamin b12 1 mg/ ml
takeda as - cyanokobalamin - injeksjonsvæske, oppløsning - 1 mg/ ml
Norveška -
norveški -
Statens legemiddelverk
vitamin b12 depot 1 mg/ ml
takeda as - hydroksokobalaminklorid - injeksjonsvæske, oppløsning - 1 mg/ ml
Europska Unija -
norveški -
EMA (European Medicines Agency)
qdenga
takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - dengue - vaksiner - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.